Thomas, Sheeba K <br/><br/>
Asian ethnicity as a predictor of response in patients with non-small-cell lung cancer treated with gefitinib on an expanded access program.  [electronic resource] 

 -  Clinical lung cancer  Mar 2006 
 - 326-31 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-7304 
<br/><br/><label>Standard No.: </label>10.3816/CLC.2006.n.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Asian People--ethnology<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Gefitinib<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Quinazolines--therapeutic use<br/>Retrospective Studies<br/>United States